VIGL
Price
$8.05
Change
-$0.00 (-0.00%)
Updated
Aug 4 closing price
Capitalization
375.71M
One day until earnings call
VTGN
Price
$2.81
Change
-$0.16 (-5.39%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
88.68M
Interact to see
Advertisement

VIGL vs VTGN

Header iconVIGL vs VTGN Comparison
Open Charts VIGL vs VTGNBanner chart's image
Vigil Neuroscience
Price$8.05
Change-$0.00 (-0.00%)
Volume$5.51M
Capitalization375.71M
VistaGen Therapeutics
Price$2.81
Change-$0.16 (-5.39%)
Volume$3.87K
Capitalization88.68M
VIGL vs VTGN Comparison Chart in %
Loading...
VIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
VIGL vs. VTGN commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VIGL is a Hold and VTGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (VIGL: $8.05 vs. VTGN: $2.97)
Brand notoriety: VIGL and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: VIGL: 330% vs. VTGN: 146%
Market capitalization -- VIGL: $375.71M vs. VTGN: $88.68M
VIGL [@Biotechnology] is valued at $375.71M. VTGN’s [@Biotechnology] market capitalization is $88.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VIGL’s FA Score shows that 0 FA rating(s) are green whileVTGN’s FA Score has 0 green FA rating(s).

  • VIGL’s FA Score: 0 green, 5 red.
  • VTGN’s FA Score: 0 green, 5 red.
According to our system of comparison, both VIGL and VTGN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VIGL’s TA Score shows that 4 TA indicator(s) are bullish while VTGN’s TA Score has 4 bullish TA indicator(s).

  • VIGL’s TA Score: 4 bullish, 2 bearish.
  • VTGN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, VIGL is a better buy in the short-term than VTGN.

Price Growth

VIGL (@Biotechnology) experienced а 0.00% price change this week, while VTGN (@Biotechnology) price change was +1.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.22%. For the same industry, the average monthly price growth was +31.78%, and the average quarterly price growth was +19.63%.

Reported Earning Dates

VIGL is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+22.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VIGL($376M) has a higher market cap than VTGN($88.7M). VIGL YTD gains are higher at: 373.529 vs. VTGN (0.678). VTGN has higher annual earnings (EBITDA): -52.22M vs. VIGL (-91.27M). VTGN (88.6M) and VIGL (87.1M) have equal amount of cash in the bank . VTGN has less debt than VIGL: VTGN (1.71M) vs VIGL (12.7M). VTGN has higher revenues than VIGL: VTGN (698K) vs VIGL (0).
VIGLVTGNVIGL / VTGN
Capitalization376M88.7M424%
EBITDA-91.27M-52.22M175%
Gain YTD373.5290.67855,096%
P/E RatioN/AN/A-
Revenue0698K-
Total Cash87.1M88.6M98%
Total Debt12.7M1.71M741%
FUNDAMENTALS RATINGS
VTGN: Fundamental Ratings
VTGN
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
VIGLVTGN
RSI
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
89%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
79%
Advances
ODDS (%)
Bullish Trend 26 days ago
87%
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
N/A
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
VIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABTZY5.640.18
+3.31%
Aboitiz Equity Ventures, Inc.
WRSLF0.12N/A
N/A
Winsome Resources Ltd.
MTGRF0.23N/A
N/A
Mount Gibson Iron Ltd.
NBGIF15.05-0.25
-1.63%
National Bank of Greece S.A.
RGBP0.04-0.01
-16.14%
Regen Biopharma, Inc.

VIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIGL has been loosely correlated with MRUS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if VIGL jumps, then MRUS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIGL
1D Price
Change %
VIGL100%
N/A
MRUS - VIGL
49%
Loosely correlated
+0.96%
IMNN - VIGL
46%
Loosely correlated
-12.60%
ELVN - VIGL
35%
Loosely correlated
-1.17%
VYGR - VIGL
32%
Poorly correlated
-2.48%
VTGN - VIGL
31%
Poorly correlated
+8.79%
More

VTGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been loosely correlated with COGT. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if VTGN jumps, then COGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
+8.79%
COGT - VTGN
41%
Loosely correlated
+0.92%
IMNM - VTGN
40%
Loosely correlated
-1.82%
RNA - VTGN
40%
Loosely correlated
-2.59%
CRSP - VTGN
39%
Loosely correlated
-1.72%
ALEC - VTGN
39%
Loosely correlated
+47.26%
More